Ascendis Pharma · 2 weeks ago
Senior Manager, Regulatory Project Manager - Job ID: 1820
Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with a focus on Endocrinology Rare Disease and Oncology. The Regulatory Project Manager will provide project management leadership to key global regulatory submissions across the Ascendis pipeline, contributing to the vision, strategy, and infrastructure of Global Regulatory Affairs.
BiotechnologyClinical TrialsHealth Care
Responsibilities
Collaborate with Global Regulatory Affairs Leadership in establishing and managing timelines for key project milestones, adhering to processes and documentation, and communicating with cross-functional teams or key stakeholders within and across regions to ensure the delivery of business objectives
Participate in Regulatory filing teams, providing project management expertise in the end-to-end planning, coordination, and execution of assigned Regulatory submissions project deliverables
Monitor submission deliverables as required to support investigational (IND/CTA) and marketing applications (BLA/NDS/MAA), and global clinical trials as required
Work with key stakeholders for major submissions, identifying risks, opportunities and mitigation strategies, ensuring successful and on-time project execution
Provide project management support to regulatory agency interactions and the preparations for the interaction
Strive for efficiency by ensuring consistent approaches and development of best practices
Qualification
Required
Degree in life science or equivalent. MS, MBA and/or PMP desired
A minimum of 8 years of experience: 5 years in drug, biologic and/or combination products in Regulatory Affairs and 3 years of experience performing directly relevant Regulatory Project Management activities within the pharmaceutical and/or biotechnology industries
Familiarity with Regulatory framework and understanding of the overall drug development process, early and late stage (IND, CTA, BLA, NDA, MAA)
Experience in participating in Regulatory filing teams with ability to look across multiple programs for submission related conflicts or resourcing constraints
Ability to identify and document all regulatory project deliverables from each functional area for global regulatory submissions
Maintain detailed timelines for global regulatory strategies for assigned therapeutic areas in US, EU, UK, CAN, and ROW, and ensure planning and coordination of activities via the Submission Project Teams
Thorough working knowledge of applicable Regulatory Agency regulations, guidelines, and/or specifications (e.g., FDA, EMA, ICH, etc.) and global eCTD submission requirements (e.g., US, EU, UK, CA)
Strong interpersonal, communication, organizational/planning, and time-management skills
Ability to present complex information in an easy-to-understand format to all levels of stakeholders
Detail-oriented with ability and desire to work in a fast paced, team oriented, small company environment, with the ability to manage simultaneous priorities and challenging deadlines
Advance proficiency with Microsoft Office Suite (Word, Excel, PowerPoint, Project), MS Project, and MS Teams
Prior experience with an EDMS required
Ability to travel up to 20% of the time domestically and internationally
Preferred
Orphan drug experience preferred
Experience with Veeva Vault Regulatory systems preferred
Benefits
401(k) plan with company match
Medical, dental, and vision plans
Company-offered Life and Accidental Death & Dismemberment (AD&D) insurance
Company-provided short and long-term disability benefits
Unique offerings of Pet Insurance and Legal Insurance
Employee Assistance Program
Employee Discounts
Professional Development
Health Saving Account (HSA)
Flexible Spending Accounts
Various incentive compensation plans
Accident, Critical Illness, and Hospital Indemnity Insurance
Mental Health resources
Paid leave benefits for new parents
Company
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
Funding
Current Stage
Public CompanyTotal Funding
$1.88BKey Investors
Royalty Pharma
2024-09-19Post Ipo Equity· $300M
2024-09-03Post Ipo Debt· $150M
2023-09-05Post Ipo Debt· $150M
Leadership Team
Recent News
2025-12-09
2025-12-01
2025-11-28
Company data provided by crunchbase